Financial reports
NT 10-K
Notice of late annual filing
30 Mar 20
NT 10-Q
Notice of late quarterly filing
15 Nov 19
NT 10-Q
Notice of late quarterly filing
12 Aug 19
10-Q
2019 Q1
Quarterly report
7 May 19
10-K/A
2018 FY
Annual report (amended)
26 Apr 19
10-K
2018 FY
Annual report
15 Mar 19
10-Q
2018 Q3
Quarterly report
13 Nov 18
10-Q
2018 Q2
Quarterly report
7 Aug 18
10-Q
2018 Q1
Quarterly report
10 May 18
10-K/A
2017 FY
Annual report (amended)
30 Apr 18
Current reports
8-K
Novelion Therapeutics Ceases to be a Reporting Issuer in Canada
14 Jul 20
8-K
Novelion Therapeutics Provides Update on Liquidation and Claims Process
12 Jun 20
8-K
Bankruptcy or Receivership
21 Jan 20
8-K
Other Events
10 Jan 20
8-K
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters
3 Jan 20
8-K
Novelion Therapeutics Provides Update on Effective Date of Liquidation
11 Dec 19
8-K
Other Events
22 Nov 19
8-K
Submission of Matters to a Vote of Security Holders
5 Nov 19
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Oct 19
8-K
Departure of Directors or Certain Officers
3 Oct 19
Registration and prospectus
25-NSE
Exchange delisting
17 Dec 19
S-8
Registration of securities for employees
31 Jul 17
S-8
Registration of securities for employees
31 Jul 17
S-8
Registration of securities for employees
5 Dec 16
S-3/A
Shelf registration (amended)
22 Nov 16
425
Business combination disclosure
1 Nov 16
425
Business combination disclosure
24 Oct 16
S-3
Shelf registration
24 Oct 16
425
Business combination disclosure
20 Oct 16
424B3
Prospectus supplement
6 Oct 16
Proxies
DEFA14A
Additional proxy soliciting materials
8 Oct 19
DEFA14A
Additional proxy soliciting materials
4 Oct 19
DEF 14A
Definitive proxy
3 Oct 19
DEFA14A
Additional proxy soliciting materials
3 Oct 19
DEFA14A
Additional proxy soliciting materials
25 Sep 19
PRE 14A
Preliminary proxy
20 Sep 19
DEF 14A
Definitive proxy
11 Jul 18
DEFA14A
Additional proxy soliciting materials
11 May 17
DEF 14A
Definitive proxy
1 May 17
DEF 14A
Definitive proxy
19 May 16
Other
REVOKED
Registration or securities revoked
10 Mar 23
CT ORDER
Confidential treatment order
18 Oct 18
EFFECT
Notice of effectiveness
29 Nov 16
CORRESP
Correspondence with SEC
25 Nov 16
UPLOAD
Letter from SEC
7 Nov 16
EFFECT
Notice of effectiveness
6 Oct 16
CORRESP
Correspondence with SEC
5 Oct 16
CORRESP
Correspondence with SEC
28 Sep 16
UPLOAD
Letter from SEC
26 Sep 16
CORRESP
Correspondence with SEC
9 Sep 16
Ownership
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G/A
Novelion Therapeutics Inc.
21 Jan 20
3
KEVIN KOTLER
15 Jan 20
SC 13G/A
Novelion Therapeutics Inc.
15 Jan 20
SC 13G/A
Novelion Therapeutics Inc.
10 Jan 20
4
Change in insider ownership
12 Dec 19
4
Change in insider ownership
9 Dec 19
4
Change in insider ownership
26 Nov 19
4
Change in insider ownership
16 Oct 19
3
Initial statement of insider ownership
2 Oct 19